Bayer, J&J's Xarelto Bests Warfarin in Key Study - BusinessWeek

[INCIID News Feed]

The Star-Ledger - NJ.com
<img alt="" height="1" width="1" />
Bayer, J&J&#39;s Xarelto Bests Warfarin in Key Study
BusinessWeek
Nov. 15 (Bloomberg) -- Johnson & Johnson and Bayer AG&#39;s blood thinner Xarelto prevented strokes in patients with an erratic heartbeat better than standard therapy with warfarin in a study, without raising the ...
Bayer, J&J anti-clot drug shines in stroke trialReuters
Bayer, J&J&#39;s Xarelto Bests Warfarin Without Raising Bleeding Risk in StudyBloomberg
Clot drug to help heart patientsBBC News
The Canadian Press -MedPage Today -NASDAQ
all 142 news articles &raquo;


More...